Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Anticancer Drugs. 2010 Aug;21(7):716–723. doi: 10.1097/CAD.0b013e32833cb658

Table 2.

Edotecarin/5-FU/LV treatment regimen

Drug Starting dose and route Dosing schedule
Edotecarin X mg/m2 IV over 1 h Day 1 Every 2 weeks
LV 200 mg/m2 IV over 2 h Day 1 Every 2 weeks
5-FU 2400 mg/m2 IV over 46 h Day 1–2 Every 2 weeks

5-FU, 5-fluorouracil; IV, intravenous; LV, leucovorin.

X Edotecarin dose level was determined from Table 3 and was assigned by the sponsor when a patient was registered for the study.